Publications found:
73,128
Sort by:
Predictive Analytics Market by Business Functions (Marketing, Sales, Finance and Human resource), Application Models (Risk Management, Operations Management, Sales & Marketing Management, Network Management, Supply Chain Management and Workforce Management), Organization Size (SMES and Large Enterprises) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
US$ 5,769.00
Predictive analytics is the use of data, statistical algorithms, and machine learning techniques to detect the likelihood of future outcomes based on historical data. Predictive analytics evaluates th...
July 2020
306 pages
Short Bowel Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Short Bowel Syndrome (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Short Bowel Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
70 pages
Small-Cell Lung Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Small-Cell Lung Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Small-Cell Lung Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
1397 pages
Bladder Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Bladder Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Bladder Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
1855 pages
Colon Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Colon Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colon Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
1184 pages
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gastrointestinal Stromal Tumor (GIST) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gastrointestinal Stromal Tumor (GIST) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
627 pages
Huntington Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Huntington Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Huntington Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
390 pages
Medulloblastoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Medulloblastoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Medulloblastoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
380 pages
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
71 pages
Myelodysplastic Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Myelodysplastic Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Myelodysplastic Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
1667 pages
Non-Small Cell Lung Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Non-Small Cell Lung Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Non-Small Cell Lung Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
4664 pages
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2020
US$ 2,500.00
... Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
3103 pages
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Glioblastoma Multiforme (GBM) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Glioblastoma Multiforme (GBM) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
2766 pages
Hypertension - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Hypertension (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
772 pages
Macular Edema - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Macular Edema (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Macular Edema and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
92 pages
Multiple Sclerosis - Pipeline Review, H1 2020
US$ 2,500.00
... . The Multiple Sclerosis (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Multiple Sclerosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
1114 pages
Colorectal Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Colorectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
3889 pages
Female Sexual Dysfunction - Pipeline Review, H1 2020
US$ 2,000.00
... . The Female Sexual Dysfunction (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Sexual Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
84 pages
Retinal Vein Occlusion - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Retinal Vein Occlusion (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinal Vein Occlusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
93 pages
Age Related Macular Degeneration - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Age Related Macular Degeneration (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Age Related Macular Degeneration and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
864 pages
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Bile Duct Cancer (Cholangiocarcinoma) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
1561 pages
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Kidney Cancer (Renal Cell Cancer) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
2815 pages
Ovarian Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Ovarian Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ovarian Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
3802 pages
Wounds - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Wounds - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Wounds (Dermatology), complete with analysis by stage of development ...
June 2020
255 pages
Neuroendocrine Tumors - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Neuroendocrine Tumors (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Neuroendocrine Tumors and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
795 pages
Keloids - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Keloids (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Keloids and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
64 pages
Peptic Ulcers - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Peptic Ulcers (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Peptic Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
65 pages
Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pituitary ACTH Hypersecretion (Cushing Disease) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Pituitary ACTH Hypersecretion (Cushing Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
42 pages
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinitis Pigmentosa (Retinitis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
260 pages
Recurrent Malignant Glioma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Recurrent Malignant Glioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Recurrent Malignant Glioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
55 pages
Progressive Supranuclear Palsy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Progressive Supranuclear Palsy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Progressive Supranuclear Palsy and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
113 pages
Western Equine Encephalitis - Pipeline Review, H1 2020
US$ 2,000.00
... . The Western Equine Encephalitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Western Equine Encephalitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
33 pages
Radiodermatitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Radiodermatitis (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiodermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
57 pages
Canavan Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Canavan Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Canavan Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
35 pages
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Cervical Intraepithelial Neoplasia (CIN) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Cervical Intraepithelial Neoplasia (CIN) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
282 pages
Encephalopathy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Encephalopathy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
81 pages
Familial Amyloid Neuropathies - Pipeline Review, H1 2020
US$ 2,000.00
... . The Familial Amyloid Neuropathies (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Familial Amyloid Neuropathies and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
98 pages
Graves' Ophthalmopathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Graves' Ophthalmopathy (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Graves' Ophthalmopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
82 pages
Hyperglycemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hyperglycemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperglycemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
35 pages
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Liver Failure (Hepatic Insufficiency) (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Liver Failure (Hepatic Insufficiency) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
103 pages
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Metachromatic Leukodystrophy (MLD) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Metachromatic Leukodystrophy (MLD) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
68 pages
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
110 pages
